References
- Klepin HD. Myelodysplastic syndromes and acute myeloid leukemia in the elderly. Clin Geriatr Med. 2016;32(1):155–173. doi:https://doi.org/10.1016/j.cger.2015.08.010.
- Hruby A, Hu FB. The epidemiology of obesity: A Big picture. Pharmacoeconomics. 2015;33(7):673–689. doi:https://doi.org/10.1007/s40273-014-0243-x.
- Djalalinia S, Qorbani M, Peykari N, et al. Health impacts of obesity. Pakistan J Med Sci. 2015;31(1):239–242. doi:https://doi.org/10.12669/pjms.311.7033.
- Ma X, Lim U, Park Y, et al. Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort. Am J Epidemiol. 2009;169(12):1492–1499. doi:https://doi.org/10.1093/aje/kwp074.
- Medeiros BC, Othus M, Estey EH, et al. Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia. Haematologica. 2012;97(9):1401–1404. doi:https://doi.org/10.3324/haematol.2011.056390.
- Voshtina E, Szabo A, Hamadani M, et al. Impact of obesity on clinical outcomes of elderly patients undergoing allogeneic hematopoietic cell transplantation for myeloid malignancies. Biol Blood Marrow Transplant. 2019;25(1):e33–e38. doi:https://doi.org/10.1016/j.bbmt.2018.08.031.
- Kraakman MJ, Kammoun HL, Dragoljevic D, et al. Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome. Haematologica. 2018;103(4):597–606. doi:https://doi.org/10.3324/haematol.2017.181958.
- Castillo JJ, Reagan JL, Ingham RR, et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res. 2012;36(7):868–875. doi:https://doi.org/10.1016/j.leukres.2011.12.020.
- Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–578. doi:https://doi.org/10.1016/S0140-6736(08)60269-X.
- Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91(1):258S–261S. doi:https://doi.org/10.3945/ajcn.2009.28449C.
- DiMascio L, Voermans C, Uqoezwa M, et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol. 2007;178(6):3511–3520. doi:https://doi.org/10.4049/jimmunol.178.6.3511.
- Dalamaga M, Nikolaidou A, Karmaniolas K, et al. Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study. Oncology. 2007;73(1-2):26–32.
- Dalamaga M, Karmaniolas K, Nikolaidou A, et al. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system. Eur J Cancer. 2008;44(12):1744–1753. doi:https://doi.org/10.1016/j.ejca.2008.04.015.
- Dalamaga M, Karmaniolas K, Chamberland J, et al. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Metab Clin Exp. 2013;62(12):1830–1839. doi:https://doi.org/10.1016/j.metabol.2013.09.007.
- Poynter JN, Richardson M, Blair CK, et al. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. Cancer Epidemiol. 2016;40:134–140. doi:https://doi.org/10.1016/j.canep.2015.12.005.
- Jabbar KJ, Yin CC, Bueso-Ramos CE, et al. Higher body mass index is associated with better survival in patients with myelodysplastic syndromes. Leuk Res. 2018;71:63–66. doi:https://doi.org/10.1016/j.leukres.2018.07.008.
- Thibaud S, Adrianzen Herrera D, Snyder R, et al. Obesity Is associated with younger age at presentation and more severe cytopenias in myelodysplastic syndromes. Blood. 2017;130(Supplement 1):5312. doi:https://doi.org/10.1182/blood.V130.Suppl_1.5312.5312.
- Hales C, Carroll M, Fryar C, et al. Prevalence of obesity and severe obesity Among adults: United States, 2017-2018. NCHS Data Brief, MMWR. 2020;69(13).